170 related articles for article (PubMed ID: 16857362)
21. Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model.
Tateno M; Sadakata H; Tanaka M; Itohara S; Shin RM; Miura M; Masuda M; Aosaki T; Urushitani M; Misawa H; Takahashi R
Hum Mol Genet; 2004 Oct; 13(19):2183-96. PubMed ID: 15294873
[TBL] [Abstract][Full Text] [Related]
22. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS.
Robertson J; Sanelli T; Xiao S; Yang W; Horne P; Hammond R; Pioro EP; Strong MJ
Neurosci Lett; 2007 Jun; 420(2):128-32. PubMed ID: 17543992
[TBL] [Abstract][Full Text] [Related]
23. Replacement of microglial cells using Clodronate liposome and bone marrow transplantation in the central nervous system of SOD1(G93A) transgenic mice as an in vivo model of amyotrophic lateral sclerosis.
Lee JC; Seong J; Kim SH; Lee SJ; Cho YJ; An J; Nam DH; Joo KM; Cha CI
Biochem Biophys Res Commun; 2012 Feb; 418(2):359-65. PubMed ID: 22269142
[TBL] [Abstract][Full Text] [Related]
24. Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models.
Jonsson PA; Graffmo KS; Andersen PM; Brännström T; Lindberg M; Oliveberg M; Marklund SL
Brain; 2006 Feb; 129(Pt 2):451-64. PubMed ID: 16330499
[TBL] [Abstract][Full Text] [Related]
25. siRNA-based inhibition specific for mutant SOD1 with single nucleotide alternation in familial ALS, compared with ribozyme and DNA enzyme.
Yokota T; Miyagishi M; Hino T; Matsumura R; Tasinato A; Urushitani M; Rao RV; Takahashi R; Bredesen DE; Taira K; Mizusawa H
Biochem Biophys Res Commun; 2004 Jan; 314(1):283-91. PubMed ID: 14715277
[TBL] [Abstract][Full Text] [Related]
26. RNA interference and amyotrophic lateral sclerosis.
Rizvanov AA; Gulluoglu S; Yalvaç ME; Palotás A; Islamov RR
Curr Drug Metab; 2011 Sep; 12(7):679-83. PubMed ID: 21740381
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic gene silencing delivered by a chemically modified small interfering RNA against mutant SOD1 slows amyotrophic lateral sclerosis progression.
Wang H; Ghosh A; Baigude H; Yang CS; Qiu L; Xia X; Zhou H; Rana TM; Xu Z
J Biol Chem; 2008 Jun; 283(23):15845-52. PubMed ID: 18367449
[TBL] [Abstract][Full Text] [Related]
28. Dysequilibrium between caspases and their inhibitors in a mouse model for amyotrophic lateral sclerosis.
Tokuda E; Ono S; Ishige K; Watanabe S; Okawa E; Ito Y; Suzuki T
Brain Res; 2007 May; 1148():234-42. PubMed ID: 17397813
[TBL] [Abstract][Full Text] [Related]
29. Heterodimer formation of wild-type and amyotrophic lateral sclerosis-causing mutant Cu/Zn-superoxide dismutase induces toxicity independent of protein aggregation.
Witan H; Kern A; Koziollek-Drechsler I; Wade R; Behl C; Clement AM
Hum Mol Genet; 2008 May; 17(10):1373-85. PubMed ID: 18211954
[TBL] [Abstract][Full Text] [Related]
30. Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels.
Zimmerman MC; Oberley LW; Flanagan SW
J Neurochem; 2007 Aug; 102(3):609-18. PubMed ID: 17394531
[TBL] [Abstract][Full Text] [Related]
31. Rapid disease progression correlates with instability of mutant SOD1 in familial ALS.
Sato T; Nakanishi T; Yamamoto Y; Andersen PM; Ogawa Y; Fukada K; Zhou Z; Aoike F; Sugai F; Nagano S; Hirata S; Ogawa M; Nakano R; Ohi T; Kato T; Nakagawa M; Hamasaki T; Shimizu A; Sakoda S
Neurology; 2005 Dec; 65(12):1954-7. PubMed ID: 16291929
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis.
Chang-Hong R; Wada M; Koyama S; Kimura H; Arawaka S; Kawanami T; Kurita K; Kadoya T; Aoki M; Itoyama Y; Kato T
Exp Neurol; 2005 Jul; 194(1):203-11. PubMed ID: 15899257
[TBL] [Abstract][Full Text] [Related]
33. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis.
Gong YH; Elliott JL
Exp Neurol; 2000 Mar; 162(1):27-36. PubMed ID: 10716886
[TBL] [Abstract][Full Text] [Related]
34. Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS.
Kirby J; Halligan E; Baptista MJ; Allen S; Heath PR; Holden H; Barber SC; Loynes CA; Wood-Allum CA; Lunec J; Shaw PJ
Brain; 2005 Jul; 128(Pt 7):1686-706. PubMed ID: 15872021
[TBL] [Abstract][Full Text] [Related]
35. Assessing the role of immuno-proteasomes in a mouse model of familial ALS.
Puttaparthi K; Van Kaer L; Elliott JL
Exp Neurol; 2007 Jul; 206(1):53-8. PubMed ID: 17482163
[TBL] [Abstract][Full Text] [Related]
36. Transgenic small interfering RNA halts amyotrophic lateral sclerosis in a mouse model.
Saito Y; Yokota T; Mitani T; Ito K; Anzai M; Miyagishi M; Taira K; Mizusawa H
J Biol Chem; 2005 Dec; 280(52):42826-30. PubMed ID: 16221675
[TBL] [Abstract][Full Text] [Related]
37. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Sharp PS; Dick JR; Greensmith L
Neuroscience; 2005; 130(4):897-910. PubMed ID: 15652988
[TBL] [Abstract][Full Text] [Related]
38. [Gene therapy of ALS with RNA interference].
Yokota T
Rinsho Shinkeigaku; 2009 Nov; 49(11):821-3. PubMed ID: 20030220
[TBL] [Abstract][Full Text] [Related]
39. Basic and clinical research on amyotrophic lateral sclerosis and other motor neuron disorders in Italy: recent findings and achievements from a network of laboratories.
Beghi E; Mennini T;
Neurol Sci; 2004 Jun; 25 Suppl 2():S41-60. PubMed ID: 15197603
[TBL] [Abstract][Full Text] [Related]
40. An enhanced U6 promoter for synthesis of short hairpin RNA.
Xia XG; Zhou H; Ding H; Affar el B; Shi Y; Xu Z
Nucleic Acids Res; 2003 Sep; 31(17):e100. PubMed ID: 12930974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
